secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001493152-26-005030
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enVVeno Medical regains Nasdaq minimum bid price compliance; reports $28M cash at year-end
--------------------------------------------------------------------------------

- Received formal Nasdaq notice confirming compliance with minimum bid price rule; closing bid ≥ $1.00 for 10 consecutive business days Jan 20 - Feb 2, 2026, matter closed.
- Cash and investments balance approximately $28 million as of December 31, 2025.
- Company expects to share additional details on 2026 strategic plans in coming weeks; believes it is well-positioned for 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000149315226005030/0001493152-26-005030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000149315226005030/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer